Arsheen Kaur 7/14/26 Arsheen Kaur 7/14/26

Katalyze AI Announces $10.5M Seed Round

Arsheen Kaur 7/14/26 Arsheen Kaur 7/14/26

Renewed Momentum for the RNA Sector in Québec with Nearly $11M in Additional Funding for AReNA

Arsheen Kaur 7/8/26 Arsheen Kaur 7/8/26

Why Canada Needs to Build its Biomanufacturing Capacity

Arsheen Kaur 6/30/26 Arsheen Kaur 6/30/26

Yellowbird Diagnostics Completes Dosing inFirst-in-Human Phase 1 Trial of NeuCaVis™

Arsheen Kaur 6/30/26 Arsheen Kaur 6/30/26

KixCare Launches Kix360° Vitals as One Million Canadian Children Go Without a Family Doctor

Arsheen Kaur 6/30/26 Arsheen Kaur 6/30/26

June Health Announces $2.4 Million Funding Round With Strategic Investment From Securian Canada

Arsheen Kaur 6/30/26 Arsheen Kaur 6/30/26

FACIT Expands with Expert Investment Committee to Grow its Oncology Portfolio

Arsheen Kaur 6/30/26 Arsheen Kaur 6/30/26

Ontario Supporting Over 1,000 Good-Paying Jobs in Life Science Sector

Arsheen Kaur 6/16/26 Arsheen Kaur 6/16/26

Canada’s National Artificial Intelligence Strategy

Doriane Rey 6/16/26 Doriane Rey 6/16/26

How Defence Spending could help Canada Beyond the Military

Doriane Rey 6/16/26 Doriane Rey 6/16/26

Decades of Nerve Science, Now in the Operating Room: Epineuron pilots Bioelectronic Platform for Peripheral Nerve Repair and Regeneration at Sunnybrook Health Sciences Centre

Arsheen Kaur 6/1/26 Arsheen Kaur 6/1/26

Government of Canada Accelerates Homegrown AI Innovation Across Greater Toronto Area

Doriane Rey 5/27/26 Doriane Rey 5/27/26

Canada’s next defence frontier: Health emergency readiness as a sovereignty imperative

Arsheen Kaur 5/19/26 Arsheen Kaur 5/19/26

Diamond Therapeutics Receives Multi-Million Dollar US Government Funding for Phase 2 Clinical Trial of Anxiety Treatment

Arsheen Kaur 5/19/26 Arsheen Kaur 5/19/26

Ontario Investing $5 Million to Strengthen Province’s Position as a Global Leader in Life Sciences

Doriane Rey 5/14/26 Doriane Rey 5/14/26

OBIO® and IPON renew multi-year collaboration to advance Ontario’s sovereign IP capacity

Doriane Rey 5/12/26 Doriane Rey 5/12/26

OBIO® partners with MUHC to evaluate CareChain, enabling advanced musculoskeletal surgical assessment and triage

Katalyze AI Announces $10.5M Seed Round

Renewed Momentum for the RNA Sector in Québec with Nearly $11M in Additional Funding for AReNA

Why Canada Needs to Build its Biomanufacturing Capacity

Yellowbird Diagnostics Completes Dosing inFirst-in-Human Phase 1 Trial of NeuCaVis™

KixCare Launches Kix360° Vitals as One Million Canadian Children Go Without a Family Doctor

June Health Announces $2.4 Million Funding Round With Strategic Investment From Securian Canada

FACIT Expands with Expert Investment Committee to Grow its Oncology Portfolio

Ontario Supporting Over 1,000 Good-Paying Jobs in Life Science Sector

Canada’s National Artificial Intelligence Strategy

How Defence Spending could help Canada Beyond the Military

Decades of Nerve Science, Now in the Operating Room: Epineuron pilots Bioelectronic Platform for Peripheral Nerve Repair and Regeneration at Sunnybrook Health Sciences Centre

Government of Canada Accelerates Homegrown AI Innovation Across Greater Toronto Area

Canada’s next defence frontier: Health emergency readiness as a sovereignty imperative

Diamond Therapeutics Receives Multi-Million Dollar US Government Funding for Phase 2 Clinical Trial of Anxiety Treatment

Ontario Investing $5 Million to Strengthen Province’s Position as a Global Leader in Life Sciences

OBIO® and IPON renew multi-year collaboration to advance Ontario’s sovereign IP capacity

OBIO® partners with MUHC to evaluate CareChain, enabling advanced musculoskeletal surgical assessment and triage

OBIO’s Queen’s Park Reception

Vena MicroAngioscope System Used in First Commercial Cases in the United States

A Step Ahead With Trexo Plus Robotic Legs